Eylea Dosing – Recommended Schedule and Injection Techniques

Getting Eylea dosing right is an important part of preserving vision and managing chronic retinal diseases such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Because treatment often involves an initial series of injections followed by ongoing maintenance, following the prescribed schedule is essential for maintaining disease control.[1]

Eylea (aflibercept) is an anti-VEGF medication used to reduce abnormal blood vessel growth and retinal swelling. Both the timing of treatment and proper intravitreal injection technique can influence clinical outcomes.

This article reviews recommended treatment schedules for different retinal conditions, best practices for injection technique, and key steps clinicians can take to support efficacy and patient safety.

Key Takeaways

• Eylea (aflibercept) requires a precise dosing schedule tailored to specific conditions like AMD, DME, DR, and RVO.
• The standard regimen typically starts with monthly injections, followed by extended maintenance intervals.
• Proper injection techniques—including sterile preparation and anatomical accuracy—are essential to avoid complications.
• Common side effects include mild eye irritation and floaters, while rare risks include retinal detachment and infection.
• Patient education improves adherence; understanding the importance of ongoing injections and possible side effects is key.
• OCT imaging helps monitor disease progression and adjust dosing schedules for optimal outcomes.
• Open patient-provider communication builds trust and enhances treatment success.

About: Doctor Medica is your trusted supplier of top-quality dermal fillers, viscosupplements, and a range of medical and aesthetic products for your practice. We offer authentic products from leading brands at the lowest prices. Contact Doctor Medica today!

Recommended products

Considering a Purchase?

Sign in to Explore Options.

Sign In

Eylea Dosing: Standard Schedules by Indication

The recommended schedule varies according to the retinal condition being treated, and following the appropriate timeline is important for preserving vision and slowing disease progression.[2]

Wet Age-Related Macular Degeneration (AMD)

• Initial Phase: 2 mg injection every 4 weeks for the first three months.
• Maintenance Phase: 2 mg injection every 8 weeks thereafter.
• Some patients may transition to 12-week intervals based on clinical response.

Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)

• Initial Phase: 2 mg injection every 4 weeks for the first five injections.
• Maintenance Phase: 2 mg every 8 weeks, possibly extending intervals based on disease stability.

Retinal Vein Occlusion (RVO)

• Initial Phase: 2 mg injection every 4 weeks.
• Continued monthly injections are recommended until vision is stable.

Individualized adjustments are often made based on patient outcomes, balancing clinical effectiveness with the burden of frequent visits.

Because many Eylea regimens involve repeated injections over an extended period, clinics also need dependable access to the medication throughout treatment. Licensed practices that buy Eylea online should work with reputable medical suppliers that can verify product authenticity and support appropriate handling and storage.

Injection Techniques and Best Practices

A successful Eylea treatment starts well before the needle touches the eye. Patient preparation, sterile protocols, and precise injection techniques all play a role.

Preparation begins with confirming the diagnosis, discussing treatment expectations, and applying topical anesthetic to reduce discomfort.

Sterile technique is critical. The ocular surface is disinfected with povidone-iodine to prevent complications such as endophthalmitis—a rare but serious infection.

Injection involves delivering 2 mg (0.05 mL) of Eylea into the vitreous cavity using a 30-gauge needle. The injection is placed at the pars plana, and rotating sites with each session helps prevent localized irritation.

Managing and Minimizing Injection-Related Complications

While Eylea is generally safe, it’s still important to be aware of potential side effects and how to handle them quickly.[3]

Common Reactions

• Mild redness or irritation
• A temporary feeling of pressure or discomfort
• Floaters from tiny air bubbles

Rare but Serious Risks

• Retinal detachment
• Eye infection (endophthalmitis)
• Elevated intraocular pressure

Timely identification and intervention help mitigate risks and protect long-term vision outcomes.

Patient Adherence and Education

Ongoing success with Eylea depends heavily on patient consistency and understanding of the treatment plan.

Key Patient Education Points

• Injection Frequency: Regular injections are necessary to maintain visual improvements.
• Side Effects: Discuss both common reactions and less typical patient concerns. For example, some patients may ask, “Does Eylea cause hair loss?” Addressing questions about possible adverse effects openly can help set realistic expectations and reinforce trust.
• Lifestyle Advice: Post-injection, patients should avoid heavy lifting and follow care instructions.
• Follow-Up: Regular check-ups are crucial for monitoring disease status and adjusting the treatment plan.

Empowered patients who understand their treatment plan are more likely to follow it consistently, leading to better long-term outcomes.

Expert Recommendations for Optimal Outcomes

Personalized dosing is key. Ophthalmologists adjust schedules based on how the retina responds—extending injection intervals when stability is achieved, or shortening them if signs of disease return.

OCT imaging (optical coherence tomography) is used regularly to assess fluid levels in the retina, offering real-time insight into disease activity and guiding treatment frequency.

Open communication between doctor and patient builds confidence. When patients feel involved in their care, they’re more likely to remain on schedule and achieve better outcomes.

Conclusion

Eylea treatment isn’t just about following a calendar—it’s a comprehensive approach that blends expert technique, ongoing monitoring, and proactive patient education.

By personalizing dosing schedules and maintaining consistent follow-up, practitioners can help patients preserve their vision and quality of life. And for patients, asking the right questions opens the door to more transparent, reassuring care.

FAQs

1. How often is Eylea administered?

It depends on the condition. Most regimens begin with monthly injections, transitioning to every 8 or 12 weeks during the maintenance phase.

2. What is the injection process like?

Eylea is injected into the vitreous cavity of the eye using a fine needle under sterile conditions with topical anesthesia for comfort.

3. What are the most common side effects?

Temporary redness, discomfort, or floaters are common and usually resolve without intervention.

4. Are there serious risks?

Rare complications include endophthalmitis, increased intraocular pressure, and retinal detachment. Patients need immediate care if these occur.

5. How can patients improve their outcomes? 

By sticking to the recommended schedule, attending follow-ups, and maintaining open communication with their ophthalmologist.

Citations

[1] Garweg, Justus G et al. “Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.” Advances in therapy vol. 39,6 (2022): 2701-2716. doi:10.1007/s12325-022-02119-z

[2] Bayer AG. Eylea 40 mg/mL Solution for Injection in a Pre-Filled Syringe: Package Leaflet—Information for the Patient. Nov. 2022, www.bayer.com/sites/default/files/eylea-pfs-pil-nov-2022-en-1.pdf.

[3] “Eylea Side Effects.” Drugs.com, medically reviewed by Philip Thornton, 9 July 2026, www.drugs.com/sfx/eylea-side-effects.html.